tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MBRX Stock Latest News

Promising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
RatingsPromising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
3d ago
MBRX
Moleculin Biotech Reports Q2 2025 Financial Results
PremiumCompany Announcements
Moleculin Biotech Reports Q2 2025 Financial Results
3d ago
MBRX
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
PremiumThe Fly
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
4d ago
MBRX
Moleculin Biotech sees cash runway into Q4
PremiumThe Fly
Moleculin Biotech sees cash runway into Q4
4d ago
MBRX
Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech
PremiumRatings
Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech
4d ago
MBRX
Moleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
PremiumPre-EarningsMoleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
6d ago
MBRX
Moleculin Biotech Reveals Promising Preclinical Data for Annamycin
Premium
Company Announcements
Moleculin Biotech Reveals Promising Preclinical Data for Annamycin
11d ago
8K
MBRX
Moleculin Biotech announces preclinical data of annamycin in liver cancer
Premium
The Fly
Moleculin Biotech announces preclinical data of annamycin in liver cancer
11d ago
MBRX
Moleculin Biotech Releases Corporate Presentation Update
PremiumCompany Announcements
Moleculin Biotech Releases Corporate Presentation Update
15d ago
8K
MBRX
Moleculin Biotech Secures European Patent for Annamycin
PremiumCompany Announcements
Moleculin Biotech Secures European Patent for Annamycin
18d ago
8K
MBRX
Moleculin Biotech receives notice of intent to grant new European patent
PremiumThe Fly
Moleculin Biotech receives notice of intent to grant new European patent
18d ago
MBRX
Moleculin Biotech Appoints Adriano Treve as Strategic Advisor
PremiumCompany Announcements
Moleculin Biotech Appoints Adriano Treve as Strategic Advisor
1M ago
8K
MBRX
Moleculin Biotech appoints Adriano Treve as strategic advisor
PremiumThe FlyMoleculin Biotech appoints Adriano Treve as strategic advisor
1M ago
MBRX
Moleculin Biotech Enters New Stock Offering Agreement
Premium
Company Announcements
Moleculin Biotech Enters New Stock Offering Agreement
1M ago
8K
MBRX
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
Premium
Ratings
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
1M ago
MBRX
Moleculin Biotech Gains Approval for Phase 2B/3 AML Study
PremiumCompany Announcements
Moleculin Biotech Gains Approval for Phase 2B/3 AML Study
1M ago
8K
MBRX
Moleculin Biotech receives approval for pivotal Phase 2B/3 study of Annamycin
PremiumThe Fly
Moleculin Biotech receives approval for pivotal Phase 2B/3 study of Annamycin
1M ago
MBRX
Moleculin Biotech Faces Nasdaq Delisting Warning
PremiumCompany Announcements
Moleculin Biotech Faces Nasdaq Delisting Warning
2M ago
8K
MBRX
Moleculin Biotech price target lowered to $13 from $20 at Roth Capital
PremiumThe Fly
Moleculin Biotech price target lowered to $13 from $20 at Roth Capital
2M ago
MBRX
Moleculin Biotech Raises $5.9M in Public Offering
PremiumCompany AnnouncementsMoleculin Biotech Raises $5.9M in Public Offering
2M ago
8K
MBRX
Moleculin Biotech prices 16.08M shares at 37c in public offering
Premium
The Fly
Moleculin Biotech prices 16.08M shares at 37c in public offering
2M ago
MBRX
Promising Developments and Regulatory Progress Drive Buy Rating for Moleculin Biotech’s Annamycin
Premium
Ratings
Promising Developments and Regulatory Progress Drive Buy Rating for Moleculin Biotech’s Annamycin
2M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >